Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe
- 24 July 2002
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 42 (7) , 862-868
- https://doi.org/10.1046/j.1537-2995.2002.00129.x
Abstract
BACKGROUND: HCV and HIV‐1 NAT of all blood donations was initiated at our institutions in January 1997 to reduce the residual risk of transfusion‐transmitted virus infections. The yield of NAT after...Keywords
This publication has 17 references indexed in Scilit:
- TaqMan 5′-Nuclease Human Immunodeficiency Virus Type 1 PCR Assay with Phage-Packaged Competitive Internal Control for High-Throughput Blood Donor ScreeningJournal of Clinical Microbiology, 2001
- Hepatitis C Virus: Routes of Infection and Genotypes in a Cohort of Anti‐HCV‐Positive French Blood DonorsVox Sanguinis, 2000
- Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter studyHepatology, 2000
- Viral clearance in hepatitis C (1b) infection: Relationship with human leukocyte antigen class II in a homogeneous populationHepatology, 2000
- Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor ScreeningNew England Journal of Medicine, 1999
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Transmission Rates of Hepatitis C Virus by Different Batches of a Contaminated Anti‐D Immunoglobulin PreparationVox Sanguinis, 1999
- Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank settingThe Lancet, 1999
- The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infectionTransfusion Medicine Reviews, 1997
- Real time quantitative PCR.Genome Research, 1996